| Literature DB >> 36072485 |
Wendan Tao1, William Robert Kwapong1, Jianyang Xie2, Zetao Wang3, Xiaonan Guo4, Junfeng Liu1, Chen Ye1, Bo Wu1, Yitian Zhao5,2, Ming Liu1.
Abstract
Background: The retina and brain share a similar embryologic origin, blood barriers, and microvasculature features. Thus, retinal imaging has been of interest in the aging population to help in the early detection of brain disorders. Imaging evaluation of brain frailty, including brain atrophy and markers of cerebral small vessel disease (CSVD), could reflect brain health in normal aging, but is costly and time-consuming. In this study, we aimed to evaluate the retinal microvasculature and its association with radiological indicators of brain frailty in normal aging adults.Entities:
Keywords: brain frailty; brain volume; cerebral small vessel disease; retinal microvasculature; swept-source optical coherence tomography
Year: 2022 PMID: 36072485 PMCID: PMC9441884 DOI: 10.3389/fnagi.2022.945964
Source DB: PubMed Journal: Front Aging Neurosci ISSN: 1663-4365 Impact factor: 5.702
FIGURE 1Illustrative image of the macular microvasculature. The superficial vascular plexus (SVC) and deep vascular plexus (DVC), which was 5 μm above the inner limiting membrane (ILM) to 25 μm below the lower layer of the inner nuclear layer (INL).
FIGURE 2Quantification of macular microvasculature of a healthy and unhealthy retina using the deep-learning algorithm. Enface images of a healthy and unhealthy retina from the swept-source optical coherence tomography angiography (SS-OCTA) were converted into a skeletonized image. Fractal dimensions using Dbox and microvascular tortuosity were extracted from the skeletonized image using MATLAB.
Clinical and neuroimaging information of study participants.
| Characteristics | Descriptive |
| Age, y | 59.43 ± 7.31 |
| Female | 89 (64.0) |
| Education, y | 12 (9–16) |
| Hypertension | 27 (19.4) |
| Diabetes mellitus | 5 (3.6) |
| Dyslipidemia | 18 (12.9) |
| Present smokers | 21 (15.1) |
| Present drinkers | 32 (23.0) |
| MMSE | 28 (27–30) |
| MoCA | 25 (23–28) |
| Presence of lacunes | 6 (4.3) |
| PWMH | 1.0 (0–1.0) |
| DWMH | 1 (1.0–1.0) |
| Presence of Microbleeds | 16 (11.5) |
| BG-EPVS | 1.0 (0–1.0) |
| CSO-EPVS | 2 (1.0–2.0) |
| Total brain volume, | 1386.99 ± 127.05 |
| White matter volume | 491.84 ± 55.18 |
| Gray matter volume | 596.82 ± 43.48 |
| Hippocampus volume | 3.85±0.34 |
| VT in SVC | 1.57±0.16 |
| Dbox in SVC | 1.63±0.03 |
| VT in DVC | 1.30±0.30 |
| Dbox in SVC | 1.70±0.01 |
Data are n (%), mean (SD) or median (IQR).
MMSE, mini-mental state examination; MoCA, Montreal Cognitive Assessment; PWMH, periventricular white matter hyperintensity; DWMH, deep white matter hyperintensity; BG-EPVS, basal ganglia-enlarged perivascular spaces; CSO-EPVS, centrum semiovale-enlarged perivascular spaces; SVC, superficial vascular complex; DVC, deep vascular complex; VT, microvascular tortuosity; Dbox, fractal dimension.
Correlation between MRI parameters and OCTA measures.
| SVC | DVC | |||||||
| Variable | VT | Dbox | VT | Dbox | ||||
| β Coefficient | β Coefficient | β Coefficient | β Coefficient | |||||
| (95% CI) | (95% CI) | (95% CI) | (95% CI) | |||||
| Total brain | 0.02 (–0.19 to 0.22) | 0.881 | − | 0.550 | 0.09 (–0.12 to 0.31) | 0.406 | 0.02 (–0.15 to 0.19) | 0.817 |
| White matter | − | 0.943 | 0.01 (–0.15 to 0.17) | 0.873 | 0.05 (–0.13 to 0.24) | 0.553 | − | 0.749 |
| Gray matter | − | 0.735 | 0.10 (–0.05 to 0.24) | 0.19 | − | 0.705 | − | 0.301 |
| Hippocampus | − | 0.385 | 0.03 (–0.14 to 0.21) | 0.721 | 0.08 (–0.09 to 0.25) | 0.386 | − | 0.706 |
|
| ||||||||
| Lacunes | 0.47 (–0.26 to 1.20) | 0.208 | 0.20 (–0.12 to 0.52) | 0.222 | − | 0.703 | 0.58 (0.15 to 0.93) | 0.007 |
| PWMH | 0.13 (–0.10 to 0.36) | 0.274 | 0.20 (–0.04 to 0.44) | 0.107 | − | 0.419 | 0.04 (–0.16 to 0.24) | 0.683 |
| DWMH | 0.31 (0.03 to 0.58) | 0.027 | 0.02 (–0.32 to 0.36) | 0.928 | − | 0.350 | − | 0.640 |
| Microbleeds | 0.20 (–0.21 to 0.61) | 0.343 | − | 0.647 | − | 0.496 | − | 0.581 |
| BG-EPVS | 0.04 (–0.21 to 0.28) | 0.774 | − | 0.162 | 0.0 (–0.24 to 0.25) | 0.983 | 0.12 (–0.07 to 0.32) | 0.221 |
| CSO-EPVS | 0.09 (–0.11 to 0.29) | 0.385 | 0.05 (–0.10 to 0.19) | 0.529 | − | 0.196 | 0.02 (–0.13 to 0.17) | 0.794 |
| MoCA | − | 0.011 | − | 0.051 | 0.05 (–0.013 to 0.104) | 0.128 | − | 0.055 |
| MMSE | − | 0.064 | − | 0.759 | 0.02 (–0.08 to 0.12) | 0.702 | − | 0.575 |
Values represent standardized mean difference in z-scores of brain MRI volumetric measures (95% confidence interval) per SD decrease in average SVD and DVC tortuosity and Dbox change.
Values are adjusted for age, sex, hypertension, diabetes mellitus, hyperlipidemia, alcohol intake, and current smokers.
Additional adjusted for education.
PWMH, periventricular white matter hyperintensity; DWMH, deep white matter hyperintensity BG-EPVS, basal ganglia-enlarged perivascular spaces; CSO-EPVS, centrum semiovale-enlarged perivascular spaces; MMSE, mini-mental state examination; MoCA, Montreal Cognitive Assessment; SVC, superficial vascular complex; DVC, deep vascular complex; VT, microvascular tortuosity; Dbox, fractal dimension parameter.